103
Views
0
CrossRef citations to date
0
Altmetric
Articles

Effects of treatment adherence and patient activation on health care utilization in chronic kidney disease

ORCID Icon &
Pages 149-159 | Received 29 Jul 2022, Accepted 20 Dec 2022, Published online: 02 Jan 2023

References

  • Alexander M, Bradbury BD, Kewalramani R, et al. Chronic kidney disease and US healthcare resource utilization in a nationally representative sample. Am J Nephrol. 2009;29(5):473–482.
  • Aubert CE, Fankhauser N, Marques-Vidal P, et al. Multimorbidity and healthcare resource utilization in Switzerland: a multicentre cohort study. BMC Health Serv Res. 2019;19(1):708.
  • Kinney RL, Lemon SC, Person SD, et al. The association between patient activation and medication adherence, hospitalization, and emergency room utilization in patients with chronic illnesses: a systematic review. Patient Educ Couns. 2015;98(5):545–552.
  • Scheppers E, Van Dongen E, Dekker J, et al. Potential barriers to the use of health services among ethnic minorities: A review. Fam Pract. 2006;23(3):325–348.
  • Loue S, Sajatovic M. Encyclopedia of immigrant health (Vol. 2). New York: Springer Science & Business Media; 2011.
  • Shimizu U, Mitadera Y, Aoki H, et al. Dialysis patients’ utilization of health care services covered by long-term care ınsurance in Japan. Tohoku J Exp Med. 2015;236(1):9–19.
  • Hibbard JH, Greene J, Sacks RM, et al. Improving population health management strategies: identifying patients who are more likely to be users of avoidable costly care and those more likely to develop a new chronic disease. Health Serv Res. 2017;52(4):1297–1309.
  • Wagner E, Patrick DL, Khandelwal N, et al. The influence of multimorbidity on health care utilization at the end of life for patients with chronic conditions. J Palliat Med. 2019;22(10):1260–1265.
  • Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272.
  • Schmaderer MS, Zimmerman L, Hertzog M, et al. Correlates of patient activation and acute care utilization among multimorbid patients. West J Nurs Res. 2016;38(10):1335–1353.
  • Vanholder R, Annemans L, Brown E, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrology. 2017;13(7):393–409.
  • Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff. 2013;32:207–214.
  • Hibbard JH, Mahoney E. Toward a theory of patient and consumer activation. Patient Educ Couns. 2010;78(3):377–381.
  • Greene J, Hibbard JH, Sacks R, et al. When patient activation levels change, health outcomes and costs change, too. Health Aff. 2015;34(3):431–437.
  • Green JA, Mor MK, Shields AM, et al. Associations of health literacy with dialysis adherence and health resource utilization in patients receiving maintenance hemodialysis. Am J Kidney Dis. 2013;62(1):73–80.
  • Javalkar K, Fenton N, Cohen S, et al. Peer reviewed: socioecologic factors as predictors of readiness for self-management and transition, medication adherence, and health care utilization among adolescents and young adults with chronic kidney disease. Prev Chronic Dis. 2014;11:117.
  • Hibbard JH, Stockard J, Mahoney ER, et al. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4):1005–1026.
  • Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med. 2012;27(5):520–526.
  • Tusa N, Kautiainen H, Elfving P, et al. Relationship between patient activation measurement and self-rated health in patients with chronic diseases. BMC Fam Pract. 2020;21:225.
  • Di Napoli A, Pezzotti P, Di Lallo D, et al. Determinants of hospitalization in a cohort of chronic dialysis patients in central Italy. J Nephrol. 2005;18(1):21–29.
  • Tavallaii SA, Ebrahimnia M, Shamspour N, et al. Effect of depression on health care utilization in patients with end-stage renal disease treated with hemodialysis. Eur J Intern Med. 2009;20(4):411–414.
  • United States Renal Data Systems. Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, UK; 2013.
  • Khan SS, Kazmi WH, Abichandani R, et al. Health care utilization among patients with chronic kidney disease. Kidney Int. 2002;62(1):229–236.
  • Bourbeau J, Julien M, Maltais F, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med. 2003;163(5):585–591.
  • Nurmi E, Haapamäki J, Paavilainen E, et al. The burden of inflammatory bowel disease on health care utilization and quality of life. Scand J Gastroenterol. 2013;48(1):51–57.
  • American Kidney Fund. Barriers to treatment adherence for dialysis patients. American Kidney Fund; 2018. Available from: http://www.kidneyfund.org/assets/pdf/akf-adherence-report.pdf.
  • Hibbard JH, Mahoney ER, Stockard J, et al. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6):1918–1930.
  • Insignia Health. (2018). Patient Activation Measure (PAM). Available from: https://www.insigniahealth.com/products/pam-survey.
  • Graffigna G, Barello S, Bonanomi A, et al. Measuring patient activation in Italy: translation, adaptation and validation of the Italian version of the patient activation measure 13 (PAM13-I). BMC Med Inform Decis Mak. 2015;15(1):1–13.
  • Rademakers J, Nijman J, van der Hoek L, et al. Measuring patient activation in The Netherlands: translation and validation of the American short form patient activation measure (PAM13). BMC Public Health. 2012;12(1):1–7.
  • Cunha CM, da Cunha DCPT, de Oliveira Manzato R, et al. Validation of the Brazilian version of the patient activation measure 13. J Nurs Meas. 2019;27(1):97–113.
  • Bomba F, Markwart H, Mühlan H, et al. Adaptation and validation of the German patient activation measure for adolescents with chronic conditions in transitional care: PAM® 13 for adolescents. Res Nurs Health. 2018;41(1):78–87.
  • Kosar C. Adaptation of patient activation measure into Turkish: reliability and validity test [Master’s thesis]. Izmir, Turkey: Dokuz Eylül University; 2015.
  • Hovinga CA, Asato MR, Manjunath R, et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008;13(2):316–322.
  • Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–834.
  • Kim Y, Evangelista LS. Relationship between illness perceptions, treatment adherence, and clinical outcomes in patients on maintenance hemodialysis. Nephrol Nurse. 2010;37(3):271–281.
  • Sequist TD, Holliday AM, Orav EJ, et al. Physician and patient tools to improve chronic kidney disease care. Am J Manag Care. 2018;24(4):107–114.
  • Ahlawat R, D’Cruz S, Tiwari P. Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: evidence from a cross-sectional study. J Pharma Care Health System. 2015;3(149):2376–0419.
  • Sutaria A, Liu L, Ahmed Z. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective. TACA. 2016;10(4):242–250.
  • Zimbudzi E, Lo C, Ranasinha S, et al. The association between patient activation and self-care practices: A cross-sectional study of an Australian population with comorbid diabetes and chronic kidney disease. Health Expect. 2017;20(6):1375–1384.
  • Senanayake SJ, Gunawardena NS, Palihawadana P, et al. Out-of-pocket expenditure in accessing healthcare services among chronic kidney disease patients in Anuradhapura district. CMJ. 2017;62(2):100–103.
  • Collins AJ, Foley RN, Chavers B, et al. US renal data system 2013 annual data report. AJKD. 2014;63(1):107–118.
  • Essue BM, Wong G, Chapman J, et al. How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC Nephr. 2013;14(1):5.
  • The Kidney Foundation of Canada. The burden of out-of-pocket costs for Canadians with kidney failure report. 2018. Available from: https://kidney.ca/KFOC/media/images/PDFs/3-2-1-NAT-Burden_of_Out-of-Pocket_Costs.pdf
  • T.R. Ministry of Health. Turkey health literacy level and related factors research. Ankara; 2018.Available from: https://sggm.saglik.gov.tr/Eklenti/39699/0/soya-rapor-1pdf.pdf
  • Begum N, Donald M, Ozolins IZ, et al. Hospital admissions, emergency department utilisation and patient activation for self-management among people with diabetes. Diabetes Res Clin Pract. 2011;93(2):260–267.
  • Bertakis KD, Azari R. Patient-centered care is associated with decreased health care utilization. J Am Board Fam Med. 2011;24(3):229–239.
  • Greene J, Hibbard JH, Sacks R, et al. When seeing the same physician, highly activated patients have better care experiences than less activated patients. Health Aff. 2013;32:1299–1305.
  • Chan KE, Thadhani RI, Maddux FW. Adherence barriers to chronic dialysis in the United States. J Am Soc Nephrol. 2014;25(11):2642–2648.
  • Som A, Groenendyk J, An T, et al. Improving dialysis adherence for high risk patients using automated messaging: proof of concept. Sci Rep. 2017;7(1):4177.
  • Dodd R, Palagyi A, Guild L, et al. The impact of out-of-pocket costs on treatment commencement and adherence in chronic kidney disease: a systematic review. Health Policy Plan. 2018;33(9):1047–1054.
  • Hirth RA, Greer SL, Albert JM, et al. Out-of-pocket spending and medication adherence among dialysis patients in twelve countries. Health Aff. 2008;27(1):89–102.
  • Balhara KS, Fisher L, El Hage N, et al. Social determinants of health associated with hemodialysis non-adherence and emergency department utilization: a pilot observational study. BMC Nephrol. 2020;21(1):1–9.
  • Plantinga LC, Jaar BG, Fink NE, et al. Frequency of patient–physician contact in chronic kidney disease care and achievement of clinical performance targets. Int J Qual Health Care. 2005;17(2):115–121.
  • Lynch DJ, McGrady AV, Nagel RW, et al. The patient-physician relationship and medical utilization. J Clin Psychiatry. 2007;9(4):266–270.
  • Imanishi Y, Fukuma S, Karaboyas A, et al. Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan. PloS One. 2017;12(3):e0170731.
  • Kamath L, Hema NG, Himamni S. A study of drug utilisation pattern in patients of chronic kidney disease at a tertiary care hospital. Int J Basic Clin Pharmacol. 2019;8(2):170–175.
  • Starfield B, Lemke KW, Herbert R, et al. Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med. 2005;3(3):215–222.
  • Dalrymple LS, Johansen KL, Romano PS, et al. Comparison of hospitalization rates among for-profit and nonprofit dialysis facilities. Clin J Am Soc Nephrol. 2014;9(1):73–81.
  • Lee DK, Chertow GM, Zenios SA. Reexploring differences among for-profit and nonprofit dialysis providers. Health Serv Res. 2010;45(3):633–646.
  • Brunelli SM, Wilson S, Krishnan M, et al. Confounders of mortality and hospitalization rate calculations for profit and nonprofit dialysis facilities: analytic augmentation. BMC Nephrol. 2014;15(1):121.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.